<p>根据公司在最近向美国证券交易委员会（SEC）的披露，AMI 资产管理公司在 2023 年第三季度将其在礼来公司（NYSE:LLY - 免费报告）持有的股份减少了 1.6%。该基金在季度内出售了 1,020 股后，持有 62,932 股该公司的股票。礼来公司约占 AMI 资产管理公司投资组合的 2.7%，使其成为该公司第 14 大持股。截止最近报告期末，AMI 资产管理公司在礼来公司的持股价值为 48,017,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>礼来的新药数据为 2026 年设定了高风险局面</li>
</ul>
<p>其他机构投资者和对冲基金最近也调整了对该公司的持股。Braun Bostich &amp; Associates Inc.在第二季度将其在礼来公司的股份增加了 2.5%。Braun Bostich &amp; Associates Inc.目前持有 527 股该公司的股票，价值 411,000 美元，此前在上个季度购买了额外的 13 股。Rise Advisors LLC 在第二季度将其在礼来公司的股份增加了 1.8%。Rise Advisors LLC 目前持有 732 股该公司的股票，价值 571,000 美元，此前在上个季度购买了额外的 13 股。Occidental Asset Management LLC 在第二季度将其在礼来公司的股份增加了 0.7%。Occidental Asset Management LLC 目前持有 1,966 股该公司的股票，价值 1,533,000 美元，此前在上个季度购买了额外的 13 股。New Insight Wealth Advisors 在第二季度将其在礼来公司的股份增加了 3.4%。New Insight Wealth Advisors 目前持有 394 股该公司的股票，价值 307,000 美元，此前在上个季度购买了额外的 13 股。最后，Dash Acquisitions Inc.在第二季度将其在礼来公司的股份增加了 2.8%。Dash Acquisitions Inc.目前持有 485 股该公司的股票，价值 387,000 美元，此前在上个季度购买了额外的 13 股。对冲基金和其他机构投资者持有该公司 82.53% 的股票。</p>
<h2>礼来公司股票上涨 0.0%</h2>
<p>礼来公司的股票在周五开盘价为 1,077.26 美元。礼来公司的 52 周最低价为 623.78 美元，52 周最高价为 1,111.99 美元。该公司的速动比率为 1.24，流动比率为 1.55，债务与股本比率为 1.71。该公司的市值为 1.02 万亿美元，市盈率为 52.70，PEG 比率为 1.09，贝塔值为 0.37。该股票的 50 日移动平均价格为 986.75 美元，200 日移动平均价格为 841.37 美元。</p>
<ul>
<li>行业轮动：2026 年的两个聪明资金动作</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最近在 10 月 30 日（星期四）公布了季度财报。该公司报告每股收益（EPS）为 7.02 美元，超出分析师一致预期的 6.42 美元，超出幅度为 0.60 美元。该季度的收入为 176 亿美元，而一致预期为 160.9 亿美元。礼来公司的股本回报率为 109.52%，净利润率为 30.99%。礼来公司的季度收入同比增长 53.9%。在去年同期，该公司每股收益为 1.18 美元。礼来公司已将 2025 财年的指导目标设定为 23.000-23.700 EPS。平均而言，卖方分析师预测礼来公司在当前年度将发布 23.48 EPS。</p>
<h2>礼来公司增加股息</h2>
<p>该公司最近还宣布了一项季度股息，将于 3 月 10 日（星期二）支付。记录在案的投资者将在 2 月 13 日（星期五）获得每股 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。这代表着每年 6.92 美元的股息和 0.6% 的收益率。除息日期为 2 月 13 日（星期五）。礼来公司的股息支付比率（DPR）为 29.35%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
<p>一些券商最近对 LLY 进行了评估。中金公司研究将礼来公司的目标价从 801.00 美元上调至 1,060.00 美元，并在 11 月 13 日的研究报告中给予该股 “中性” 评级。Cantor Fitzgerald 在 12 月 1 日的研究报告中重新发布了对礼来公司股票的 “增持” 评级。Sanford C. Bernstein 在 12 月 19 日的研究报告中重申了对礼来公司股票的 “跑赢大盘” 评级。Wall Street Zen 在 11 月 1 日的报告中将礼来公司的股票评级从 “买入” 上调至 “强力买入”。最后，摩根大通将礼来公司的股票目标价从 1,050.00 美元上调至 1,150.00 美元，并在 11 月 18 日的报告中给予该公司 “增持” 评级。四位分析师对该股票给予了 “强力买入” 评级，十七位分析师给予了 “买入” 评级，五位分析师给予了 “持有” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 1,155.36 美元。</p>
<p><strong>阅读我们最新的 LLY 股票分析</strong></p>
<h2>礼来公司简介</h2>
<p>（免费报告）</p>
<p>礼来公司 NYSE: LLY 是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来在北美、欧洲、亚洲及其他地区维持运营和商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
<h2>阅读更多</h2>
<ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>华尔街选股者评选 2026 年第一只股票</li>
<li>[紧急！] SpaceX 即将上市！– IPO 前的动态</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>华盛顿为战争做准备</li>
<li>距离崩盘还有一个月</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>AMI 资产管理公司在第三季度减少了对礼来的持股比例，下降了 1.6%，出售了 1,020 股。礼来的股票开盘价为 1,077.26 美元，52 周区间为 623.78 美元至 1,111.99 美元。该公司报告第三季度每股收益为 7.02 美元，超出预期，并将股息提高至每股 1.73 美元。分析师预测公司将实现增长，2025 财年的每股收益指导为 23.000-23.700</p>

<p>AMI Asset Management Corp trimmed its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 62,932 shares of the company's stock after selling 1,020 shares during the quarter. Eli Lilly and Company comprises about 2.7% of AMI Asset Management Corp's investment portfolio, making the stock its 14th largest holding. AMI Asset Management Corp's holdings in Eli Lilly and Company were worth $48,017,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>根据公司在最近向美国证券交易委员会（SEC）的披露，AMI 资产管理公司在 2023 年第三季度将其在礼来公司（NYSE:LLY - 免费报告）持有的股份减少了 1.6%。该基金在季度内出售了 1,020 股后，持有 62,932 股该公司的股票。礼来公司约占 AMI 资产管理公司投资组合的 2.7%，使其成为该公司第 14 大持股。截止最近报告期末，AMI 资产管理公司在礼来公司的持股价值为 48,017,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来的新药数据为 2026 年设定了高风险局面</li>
</ul>
</div><p>Other institutional investors and hedge funds have also recently modified their holdings of the company. Braun Bostich &amp; Associates Inc. increased its position in shares of Eli Lilly and Company by 2.5% during the second quarter. Braun Bostich &amp; Associates Inc. now owns 527 shares of the company's stock worth $411,000 after purchasing an additional 13 shares in the last quarter. Rise Advisors LLC grew its stake in Eli Lilly and Company by 1.8% during the 2nd quarter. Rise Advisors LLC now owns 732 shares of the company's stock worth $571,000 after buying an additional 13 shares during the last quarter. Occidental Asset Management LLC increased its position in Eli Lilly and Company by 0.7% during the 2nd quarter. Occidental Asset Management LLC now owns 1,966 shares of the company's stock valued at $1,533,000 after buying an additional 13 shares in the last quarter. New Insight Wealth Advisors increased its position in Eli Lilly and Company by 3.4% during the 2nd quarter. New Insight Wealth Advisors now owns 394 shares of the company's stock valued at $307,000 after buying an additional 13 shares in the last quarter. Finally, Dash Acquisitions Inc. raised its stake in Eli Lilly and Company by 2.8% in the second quarter. Dash Acquisitions Inc. now owns 485 shares of the company's stock valued at $387,000 after buying an additional 13 shares during the last quarter. Hedge funds and other institutional investors own 82.53% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金最近也调整了对该公司的持股。Braun Bostich &amp; Associates Inc.在第二季度将其在礼来公司的股份增加了 2.5%。Braun Bostich &amp; Associates Inc.目前持有 527 股该公司的股票，价值 411,000 美元，此前在上个季度购买了额外的 13 股。Rise Advisors LLC 在第二季度将其在礼来公司的股份增加了 1.8%。Rise Advisors LLC 目前持有 732 股该公司的股票，价值 571,000 美元，此前在上个季度购买了额外的 13 股。Occidental Asset Management LLC 在第二季度将其在礼来公司的股份增加了 0.7%。Occidental Asset Management LLC 目前持有 1,966 股该公司的股票，价值 1,533,000 美元，此前在上个季度购买了额外的 13 股。New Insight Wealth Advisors 在第二季度将其在礼来公司的股份增加了 3.4%。New Insight Wealth Advisors 目前持有 394 股该公司的股票，价值 307,000 美元，此前在上个季度购买了额外的 13 股。最后，Dash Acquisitions Inc.在第二季度将其在礼来公司的股份增加了 2.8%。Dash Acquisitions Inc.目前持有 485 股该公司的股票，价值 387,000 美元，此前在上个季度购买了额外的 13 股。对冲基金和其他机构投资者持有该公司 82.53% 的股票。</p>
</div><h2>Eli Lilly and Company Stock Up 0.0%</h2>
<div class="lb-trans"><h2>礼来公司股票上涨 0.0%</h2>
</div><p>Shares of LLY opened at $1,077.26 on Friday. Eli Lilly and Company has a 52 week low of $623.78 and a 52 week high of $1,111.99. The company has a quick ratio of 1.24, a current ratio of 1.55 and a debt-to-equity ratio of 1.71. The company has a market capitalization of $1.02 trillion, a price-to-earnings ratio of 52.70, a PEG ratio of 1.09 and a beta of 0.37. The stock's 50-day moving average price is $986.75 and its 200-day moving average price is $841.37.</p>
<div class="lb-trans"><p>礼来公司的股票在周五开盘价为 1,077.26 美元。礼来公司的 52 周最低价为 623.78 美元，52 周最高价为 1,111.99 美元。该公司的速动比率为 1.24，流动比率为 1.55，债务与股本比率为 1.71。该公司的市值为 1.02 万亿美元，市盈率为 52.70，PEG 比率为 1.09，贝塔值为 0.37。该股票的 50 日移动平均价格为 986.75 美元，200 日移动平均价格为 841.37 美元。</p>
</div><ul>
<li>Sector Rotation: 2 Smart Money Moves for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>行业轮动：2026 年的两个聪明资金动作</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its quarterly earnings results on Thursday, October 30th. The company reported $7.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.42 by $0.60. The company had revenue of $17.60 billion during the quarter, compared to the consensus estimate of $16.09 billion. Eli Lilly and Company had a return on equity of 109.52% and a net margin of 30.99%.Eli Lilly and Company's revenue for the quarter was up 53.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.18 earnings per share. Eli Lilly and Company has set its FY 2025 guidance at 23.000-23.700 EPS. On average, sell-side analysts predict that Eli Lilly and Company will post 23.48 EPS for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最近在 10 月 30 日（星期四）公布了季度财报。该公司报告每股收益（EPS）为 7.02 美元，超出分析师一致预期的 6.42 美元，超出幅度为 0.60 美元。该季度的收入为 176 亿美元，而一致预期为 160.9 亿美元。礼来公司的股本回报率为 109.52%，净利润率为 30.99%。礼来公司的季度收入同比增长 53.9%。在去年同期，该公司每股收益为 1.18 美元。礼来公司已将 2025 财年的指导目标设定为 23.000-23.700 EPS。平均而言，卖方分析师预测礼来公司在当前年度将发布 23.48 EPS。</p>
</div><h2>Eli Lilly and Company Increases Dividend</h2>
<div class="lb-trans"><h2>礼来公司增加股息</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Friday, February 13th will be given a dividend of $1.73 per share. This is a boost from Eli Lilly and Company's previous quarterly dividend of $1.50. This represents a $6.92 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, February 13th. Eli Lilly and Company's dividend payout ratio (DPR) is 29.35%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 3 月 10 日（星期二）支付。记录在案的投资者将在 2 月 13 日（星期五）获得每股 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。这代表着每年 6.92 美元的股息和 0.6% 的收益率。除息日期为 2 月 13 日（星期五）。礼来公司的股息支付比率（DPR）为 29.35%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
</div><p>A number of brokerages have recently weighed in on LLY. CICC Research boosted their price target on Eli Lilly and Company from $801.00 to $1,060.00 and gave the stock a &#34;neutral&#34; rating in a research note on Thursday, November 13th. Cantor Fitzgerald reissued an &#34;overweight&#34; rating on shares of Eli Lilly and Company in a research report on Monday, December 1st. Sanford C. Bernstein restated an &#34;outperform&#34; rating on shares of Eli Lilly and Company in a research note on Friday, December 19th. Wall Street Zen raised shares of Eli Lilly and Company from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, November 1st. Finally, JPMorgan Chase &amp; Co. boosted their price objective on shares of Eli Lilly and Company from $1,050.00 to $1,150.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, November 18th. Four analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $1,155.36.</p>
<div class="lb-trans"><p>一些券商最近对 LLY 进行了评估。中金公司研究将礼来公司的目标价从 801.00 美元上调至 1,060.00 美元，并在 11 月 13 日的研究报告中给予该股 “中性” 评级。Cantor Fitzgerald 在 12 月 1 日的研究报告中重新发布了对礼来公司股票的 “增持” 评级。Sanford C. Bernstein 在 12 月 19 日的研究报告中重申了对礼来公司股票的 “跑赢大盘” 评级。Wall Street Zen 在 11 月 1 日的报告中将礼来公司的股票评级从 “买入” 上调至 “强力买入”。最后，摩根大通将礼来公司的股票目标价从 1,050.00 美元上调至 1,150.00 美元，并在 11 月 18 日的报告中给予该公司 “增持” 评级。四位分析师对该股票给予了 “强力买入” 评级，十七位分析师给予了 “买入” 评级，五位分析师给予了 “持有” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 1,155.36 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on LLY</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 LLY 股票分析</strong></p>
</div><h2>Eli Lilly and Company Profile</h2>
<div class="lb-trans"><h2>礼来公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company NYSE: LLY is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.</p>
<div class="lb-trans"><p>礼来公司 NYSE: LLY 是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来在北美、欧洲、亚洲及其他地区维持运营和商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>Wall Street Stockpicker Names #1 Stock of 2026</li>
<li>[URGENT!] SpaceX Going Public! – Pre-IPO Action</li>
<li>ALERT: Drop these 5 stocks before January 2026!</li>
<li>Washington prepares for war</li>
<li>A month before the crash</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>华尔街选股者评选 2026 年第一只股票</li>
<li>[紧急！] SpaceX 即将上市！– IPO 前的动态</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>华盛顿为战争做准备</li>
<li>距离崩盘还有一个月</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

AMI 资产管理公司出售了 1,020 股礼来公司（Eli Lilly）的股票 $LLY